# Venous Thromboembolism Diagnosis and Management

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the prevention, diagnosis, and treatment of venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis. It covers various aspects such as antithrombotic therapy, risk factors, prophylaxis, and management in patients with cancer. The cluster also discusses the development of clinical practice guidelines for VTE. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10285 |
| Works | 604 |

## Topic papers all

Showing 15 of 604.

- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack](https://scholariq.org/papers/guidelines-for-the-prevention-of-stroke-in-patients-with-stroke-and-transient/)
- [2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)](https://scholariq.org/papers/2019-esc-guidelines-for-the-diagnosis-and-management-of-acute-pulmonary-embolism/)
- [Validation of Clinical Classification Schemes for Predicting Stroke](https://scholariq.org/papers/validation-of-clinical-classification-schemes-for-predicting-stroke/)
- [2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism](https://scholariq.org/papers/2014-esc-guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism/)
- [COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up](https://scholariq.org/papers/covid-19-and-thrombotic-or-thromboembolic-disease-implications-for-prevention/)
- [Prevention of VTE in Nonsurgical Patients](https://scholariq.org/papers/prevention-of-vte-in-nonsurgical-patients/)
- [2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease](https://scholariq.org/papers/2016-aha-acc-guideline-on-the-management-of-patients-with-lower-extremity/)
- [Prognosis of Cancers Associated with Venous Thromboembolism](https://scholariq.org/papers/prognosis-of-cancers-associated-with-venous-thromboembolism/)
- [Coagulation abnormalities and thrombosis in patients with COVID-19](https://scholariq.org/papers/coagulation-abnormalities-and-thrombosis-in-patients-with-covid-19/)
- [2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction](https://scholariq.org/papers/2007-focused-update-of-the-acc-aha-2004-guidelines-for-the-management-of-2/)
- [Idarucizumab for Dabigatran Reversal](https://scholariq.org/papers/idarucizumab-for-dabigatran-reversal/)
- [American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism](https://scholariq.org/papers/american-society-of-hematology-2020-guidelines-for-management-of-venous/)
- [A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis](https://scholariq.org/papers/a-comparison-of-low-molecular-weight-heparin-administered-primarily-at-home-with/)
- [2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation](https://scholariq.org/papers/2021-european-heart-rhythm-association-practical-guide-on-the-use-of-non-vitamin/)

## Topic primary papers

Showing 15 of 251.

- [2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)](https://scholariq.org/papers/2019-esc-guidelines-for-the-diagnosis-and-management-of-acute-pulmonary-embolism/)
- [2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism](https://scholariq.org/papers/2014-esc-guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism/)
- [COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up](https://scholariq.org/papers/covid-19-and-thrombotic-or-thromboembolic-disease-implications-for-prevention/)
- [Prevention of VTE in Nonsurgical Patients](https://scholariq.org/papers/prevention-of-vte-in-nonsurgical-patients/)
- [Prognosis of Cancers Associated with Venous Thromboembolism](https://scholariq.org/papers/prognosis-of-cancers-associated-with-venous-thromboembolism/)
- [American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism](https://scholariq.org/papers/american-society-of-hematology-2020-guidelines-for-management-of-venous/)
- [A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis](https://scholariq.org/papers/a-comparison-of-low-molecular-weight-heparin-administered-primarily-at-home-with/)
- [Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE](https://scholariq.org/papers/venous-thromboembolic-complications-vte-in-children-first-analyses-of-the/)
- [Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial](https://scholariq.org/papers/long-term-outcome-after-additional-catheter-directed-thrombolysis-versus/)
- [Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data](https://scholariq.org/papers/rates-of-initial-and-recurrent-thromboembolic-disease-among-patients-with/)
- [American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer](https://scholariq.org/papers/american-society-of-hematology-2021-guidelines-for-management-of-venous/)
- [American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients](https://scholariq.org/papers/american-society-of-hematology-2018-guidelines-for-management-of-venous/)
- [Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis](https://scholariq.org/papers/editor-s-choice-european-society-for-vascular-surgery-esvs-2021-clinical/)
- [Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer](https://scholariq.org/papers/rivaroxaban-for-thromboprophylaxis-in-high-risk-ambulatory-patients-with-cancer/)
- [Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19](https://scholariq.org/papers/scientific-and-standardization-committee-communication-clinical-guidance-on-the/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.